| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accessing of recombinant human monoclonal antibodies from patient libraries by eukaryotic ribosome display
|
Tang, Jie
|
|
2012
|
|
1-2 |
p. 1-11
|
artikel
|
| 2 |
Adjuvants for Clostridium tetani and Clostridium diphtheriae vaccines updating
|
Alshanqiti, Fatimah M.
|
|
2017
|
|
1-2 |
p. 23-29
|
artikel
|
| 3 |
A human monoclonal antibody with the capacity to neutralize Staphylococcus aureus alpha-toxin
|
Heveker, Nikolaus
|
|
2013
|
|
1-2 |
p. 18-24
|
artikel
|
| 4 |
A molecular case-control study of association of HNF1A gene polymorphisms (rs2259816 and rs7310409) with risk of coronary artery disease in Iranian patients
|
Barzi, Samaneh Adami
|
|
2017
|
|
1-2 |
p. 65-70
|
artikel
|
| 5 |
Anti-bacterial specificities in the human fetal B cell repertoire
|
Settmacher, Utz
|
|
2013
|
|
1-2 |
p. 91-95
|
artikel
|
| 6 |
Anti-Tn human monoclonal antibodies generated following active immunization with partially desialylated ovine submaxillary mucin
|
O'Boyle, Kevin P.
|
|
2013
|
|
1-2 |
p. 25-31
|
artikel
|
| 7 |
Association of lupus anticoagulants with risk factors for obstetric complications and adverse gestational outcome
|
Cagan, Murat
|
|
|
|
1-2 |
p. 1-8
|
artikel
|
| 8 |
Comparison of expression of a humanized monoclonal antibody in mouse NSO myeloma cells and Chinese Hamster Ovary cells
|
Peakman, Timothy C.
|
|
2013
|
|
1-2 |
p. 65-74
|
artikel
|
| 9 |
Conference program
|
|
|
2002
|
|
1-2 |
p. 49-54
|
artikel
|
| 10 |
Conference Program
|
|
|
2008
|
|
1-2 |
p. 38-43
|
artikel
|
| 11 |
Conference program
|
|
|
2008
|
|
1-2 |
p. 61-66
|
artikel
|
| 12 |
Construction and characterization of chimeric and humanized forms of a broadly neutralizing monoclonal antibody to HIV-1
|
Major, Joseph G.
|
|
2013
|
|
1-2 |
p. 9-17
|
artikel
|
| 13 |
Construction of scFv library of human antibodies against tetanus toxin
|
Nejad, Hamideh Rouhani
|
|
2015
|
|
1-2 |
p. 21-26
|
artikel
|
| 14 |
Construction of scFv library of human antibodies against tetanus toxin
|
Nejad, Hamideh Rouhani
|
|
2015
|
|
1-2 |
p. 21-26
|
artikel
|
| 15 |
Design and analysis of PCR primers for the amplification and cloning of human immunoglobulin Fab fragments
|
de Boer, Mark
|
|
2013
|
|
1-2 |
p. 57-64
|
artikel
|
| 16 |
Detection and characterization of syndecan-1-associated heparan sulfate 6-O-sulfated motifs overexpressed in multiple myeloma cells using single chain antibody variable fragments
|
Delcommenne, Marc
|
|
2012
|
|
1-2 |
p. 29-40
|
artikel
|
| 17 |
Determination of dissociation constants of Anti-ALP monoclonal antibodies by an ELISA – based method
|
Naseri, Mohsen
|
|
2015
|
|
1-2 |
p. 1-5
|
artikel
|
| 18 |
Determination of dissociation constants of Anti-ALP monoclonal antibodies by an ELISA – based method
|
Naseri, Mohsen
|
|
2015
|
|
1-2 |
p. 1-5
|
artikel
|
| 19 |
Developing and mature human granulocytes express ELP 6 in the cytoplasm
|
Wagner, Lori A.
|
|
2013
|
|
1-2 |
p. 21-29
|
artikel
|
| 20 |
Development and characterization of monoclonal antibodies against human epidermal growth factor receptor in Balb/c mice
|
Baradaran, Behzad
|
|
2009
|
|
1-2 |
p. 11-16
|
artikel
|
| 21 |
Development and characterization of monoclonal antibodies against human IgA in Balb/c mice
|
Ezzatifar, Fatemeh
|
|
2015
|
|
1-2 |
p. 7-12
|
artikel
|
| 22 |
Development and characterization of monoclonal antibodies against human IgA in Balb/c mice
|
Ezzatifar, Fatemeh
|
|
2015
|
|
1-2 |
p. 7-12
|
artikel
|
| 23 |
Downstream characterization of anti-TNF-α single chain variable fragment antibodies
|
Abdolalizadeh, Jalal
|
|
2012
|
|
1-2 |
p. 41-48
|
artikel
|
| 24 |
Epitope analysis of Japanese cedar pollen allergen Cry j2 with a human IgM class monoclonal antibody 404-117
|
Chiba, Seiya
|
|
2017
|
|
1-2 |
p. 17-21
|
artikel
|
| 25 |
Erratum
|
|
|
2009
|
|
1-2 |
p. 45
|
artikel
|
| 26 |
Establishment of humanized anti-interleukin-5 receptor alpha chain monoclonal antibodies having a potent neutralizing activity
|
Koike, Masamichi
|
|
2009
|
|
1-2 |
p. 17-27
|
artikel
|
| 27 |
Frequency of viral infections and environmental factors in multiple sclerosis
|
Eftekharian, Mohammad Mahdi
|
|
2016
|
|
1-2 |
p. 17-23
|
artikel
|
| 28 |
Future prospects of monoclonal antibodies as magic bullets in Immunotherapy
|
Maleki, Leili Aghebati
|
|
2013
|
|
1-2 |
p. 9-13
|
artikel
|
| 29 |
Generation of mouse-human hybridomas secreting human monoclonal antibodies to Japanese cedar pollen allergen Cry j1
|
Yasunori Naganawa
|
|
2006
|
|
1-2 |
p. 27-31
|
artikel
|
| 30 |
High-resolution analysis of the B cell repertoire before and after polyethylene glycol fusion reveals preferential fusion of rare antigen-specific B cells
|
Dubois, Axel R.S.X.
|
|
2016
|
|
1-2 |
p. 1-15
|
artikel
|
| 31 |
Human antibodies targeting CD30^{+} lymphomas
|
Wezler, Xenia
|
|
2012
|
|
1-2 |
p. 13-28
|
artikel
|
| 32 |
Humanization of the murine anti-human CD3 monoclonal antibody OKT3
|
Adair, John R.
|
|
2013
|
|
1-2 |
p. 41-47
|
artikel
|
| 33 |
Human monoclonal antibodies recognize early and late viral proteins of human cytomegalovirus
|
Alexander, Hermann
|
|
2013
|
|
1-2 |
p. 81-90
|
artikel
|
| 34 |
Human monoclonal antibody 2909 binds to pseudovirions expressing trimers but not monomeric HIV-1 envelope proteins
|
Kimura, Tetsuya
|
|
2009
|
|
1-2 |
p. 35-40
|
artikel
|
| 35 |
Human monoclonal Fab fragments from a combinatorial library prepared from an individual with a low serum titer to a virus
|
Bender, Eckhard
|
|
2013
|
|
1-2 |
p. 3-8
|
artikel
|
| 36 |
Immunoglobulin G follow-up and immune response longevity analysis in SARS-CoV-2 convalescent patients and vaccinated individuals: A longitudinal analysis
|
Maki, Fadia Mothafar
|
|
|
|
1-2 |
p. 19-25
|
artikel
|
| 37 |
Investigation of the correlation between some immune system and biochemical indicators in patients with type 2 diabetes
|
Eftekharian, Mohammad Mahdi
|
|
2016
|
|
1-2 |
p. 25-31
|
artikel
|
| 38 |
Isolation and characterization of anti ROR1 single chain fragment variable antibodies using phage display technique
|
Aghebati-Maleki, Leili
|
|
2017
|
|
1-2 |
p. 57-63
|
artikel
|
| 39 |
Keynotes
|
|
|
2002
|
|
1-2 |
p. 1-2
|
artikel
|
| 40 |
Monoclonal and recombinant antibodies, 30 years after …
|
Emmanuelle Laffly
|
|
2006
|
|
1-2 |
p. 33-55
|
artikel
|
| 41 |
Multiple sclerosis and immunological-related risk factors: Results from a case-control study
|
Eftekharian, Mohammad Mahdi
|
|
2015
|
|
1-2 |
p. 31-36
|
artikel
|
| 42 |
Multiple sclerosis and immunological-related risk factors: Results from a case-control study
|
Eftekharian, Mohammad Mahdi
|
|
2015
|
|
1-2 |
p. 31-36
|
artikel
|
| 43 |
Novel antiphospholipid antibodies in autoimmune bullous diseases
|
Sagi, Lior
|
|
2015
|
|
1-2 |
p. 27-30
|
artikel
|
| 44 |
Novel antiphospholipid antibodies in autoimmune bullous diseases
|
Sagi, Lior
|
|
2015
|
|
1-2 |
p. 27-30
|
artikel
|
| 45 |
Of patents and patent disputes: The TNFα patent files. Part 1: Humira
|
Storz, Ulrich
|
|
2017
|
|
1-2 |
p. 1-16
|
artikel
|
| 46 |
Patterns of dengue virus IgM and IgG antibodies in suspected cases of dengue in Jamaica, 2003–2006
|
Brown, Michelle G.
|
|
2009
|
|
1-2 |
p. 29-34
|
artikel
|
| 47 |
Phage surface presentation and secretion of antibody fragments using an adaptable phagemid vector
|
Lah, Maria
|
|
2013
|
|
1-2 |
p. 48-56
|
artikel
|
| 48 |
Poster session
|
|
|
2002
|
|
1-2 |
p. 29-48
|
artikel
|
| 49 |
Poster Session
|
|
|
2003
|
|
1-2 |
p. 37-50
|
artikel
|
| 50 |
Poster Session
|
|
|
2004
|
|
1-2 |
p. 41-45
|
artikel
|
| 51 |
Poster session
|
|
|
2006
|
|
1-2 |
p. 41-52
|
artikel
|
| 52 |
Poster Session
|
|
|
2008
|
|
1-2 |
p. 45-60
|
artikel
|
| 53 |
Poster Session
|
|
|
2008
|
|
1-2 |
p. 33-38
|
artikel
|
| 54 |
Postural orthostatic tachycardia syndrome-like symptoms following COVID-19 vaccination: An overview of clinical literature
|
TV, Phu
|
|
|
|
1-2 |
p. 9-17
|
artikel
|
| 55 |
Presence of aberrant V_{H}6 domains in anti-interferon-γ autoantibodies in multiple sclerosis
|
Tyumentseva, Marina A.
|
|
2013
|
|
1-2 |
p. 31-49
|
artikel
|
| 56 |
Prevalence of tetanus immunity in the Egyptian population
|
Redwan, EL-Rashdy M.
|
|
2002
|
|
1-2 |
p. 55-59
|
artikel
|
| 57 |
Production and characterization of monoclonal antibodies against human IgG in Balb/c mouse
|
J. Majidi
|
|
2006
|
|
1-2 |
p. 1-5
|
artikel
|
| 58 |
Production and characterization of murine monoclonal antibody against synthetic peptide of CD34
|
Maleki, Leili Aghebati
|
|
2013
|
|
1-2 |
p. 1-8
|
artikel
|
| 59 |
Production of IgE antibody to Japanese cedar pollen allergen Cry j1 by short term culture of human peripheral blood lymphocytes
|
Shinmoto, Hiroshi
|
|
2009
|
|
1-2 |
p. 41-43
|
artikel
|
| 60 |
Production of monoclonal antibody against alkaline phosphatase
|
M.M. Eftekharian
|
|
2006
|
|
1-2 |
p. 17-21
|
artikel
|
| 61 |
Protein microarrays: A new tool for profiling antibody cross-reactivity
|
Paul F. Predki
|
|
2006
|
|
1-2 |
p. 7-15
|
artikel
|
| 62 |
Secretion of human monoclonal antibody after fusion of an immortal T cell line and lymphocytes from the peripheral blood of a patient with colon carcinoma
|
Dillman, Susanne L.
|
|
2013
|
|
1-2 |
p. 32-40
|
artikel
|
| 63 |
Sensitive antibody-based CTCs detection from peripheral blood
|
Shahneh, Fatemeh Zare
|
|
2013
|
|
1-2 |
p. 51-54
|
artikel
|
| 64 |
Seroprevalence and diagnosis of HIV, HBV, HCV and syphilis infections among blood donors
|
Tafesse, Tadesse Bekele
|
|
2017
|
|
1-2 |
p. 39-55
|
artikel
|
| 65 |
Serum preparation and methods for the large-scale production of IgG monoclonal antibody
|
Zeng, Quing S.
|
|
2013
|
|
1-2 |
p. 75-80
|
artikel
|
| 66 |
Session 4: Advances in technologyWednesday 12th November 2008. Moderator: Mark Glassy
|
|
|
2008
|
|
1-2 |
p. 7-9
|
artikel
|
| 67 |
Session 5: Antibody repertoireTuesday 30th October 2007. Moderator: To be confirmed
|
|
|
2008
|
|
1-2 |
p. 23-24
|
artikel
|
| 68 |
Session 8: Anti-infective, anti-bacterial/viral antibodies: A new emerging paradigm in the field of anti-infectives - I
|
|
|
2006
|
|
1-2 |
p. 37
|
artikel
|
| 69 |
Session 9: Anti-infective, anti-bacterial/viral antibodies: A new emerging paradigm in the field of anti-infectives - II
|
|
|
2006
|
|
1-2 |
p. 39-40
|
artikel
|
| 70 |
Session 7: Applied technologies
|
|
|
2006
|
|
1-2 |
p. 33-36
|
artikel
|
| 71 |
Session 9: Applied technologies - I
|
|
|
2003
|
|
1-2 |
p. 25-26
|
artikel
|
| 72 |
Session 9: Applied technologies - I
|
|
|
2004
|
|
1-2 |
p. 31-32
|
artikel
|
| 73 |
Session 10: Applied technologies - II
|
|
|
2003
|
|
1-2 |
p. 27-35
|
artikel
|
| 74 |
Session 10: Applied technologies - II
|
|
|
2004
|
|
1-2 |
p. 33-37
|
artikel
|
| 75 |
Session 11: Applied technologies - III
|
|
|
2004
|
|
1-2 |
p. 39-40
|
artikel
|
| 76 |
Session 11: Applied technologies IIWednesday 31st October 2007. Moderator: To be confirmed
|
|
|
2008
|
|
1-2 |
p. 37-42
|
artikel
|
| 77 |
Session 10: Applied technologies IWednesday 31st October 2007. Moderator: To be confirmed
|
|
|
2008
|
|
1-2 |
p. 35-36
|
artikel
|
| 78 |
Session 2: Autoimmunity
|
|
|
2002
|
|
1-2 |
p. 9-12
|
artikel
|
| 79 |
Session 5: Autoimmunity
|
|
|
2004
|
|
1-2 |
p. 13-14
|
artikel
|
| 80 |
Session 1: Cancer
|
|
|
2002
|
|
1-2 |
p. 3-7
|
artikel
|
| 81 |
Session 1: Cancer - I
|
|
|
2006
|
|
1-2 |
p. 1-2
|
artikel
|
| 82 |
Session 2: Cancer - I
|
|
|
2003
|
|
1-2 |
p. 3
|
artikel
|
| 83 |
Session 2: Cancer - I
|
|
|
2004
|
|
1-2 |
p. 3-4
|
artikel
|
| 84 |
Session 3: Cancer - II
|
|
|
2003
|
|
1-2 |
p. 5-6
|
artikel
|
| 85 |
Session 2: Cancer - II
|
|
|
2006
|
|
1-2 |
p. 3-8
|
artikel
|
| 86 |
Session 3: Cancer - II
|
|
|
2004
|
|
1-2 |
p. 5-7
|
artikel
|
| 87 |
Session 4: Cancer - III
|
|
|
2003
|
|
1-2 |
p. 7-9
|
artikel
|
| 88 |
Session 4: Cancer - III
|
|
|
2004
|
|
1-2 |
p. 9-11
|
artikel
|
| 89 |
Session 3: Cancer - III
|
|
|
2006
|
|
1-2 |
p. 9-13
|
artikel
|
| 90 |
Session 6: Cancer IIITuesday 30th October 2007. Moderators: To be confirmed
|
|
|
2008
|
|
1-2 |
p. 25-26
|
artikel
|
| 91 |
Session 3: Cancer IIMonday 29th October 2007. Moderators: Peter Vollmers and Kathy Potter
|
|
|
2008
|
|
1-2 |
p. 5-11
|
artikel
|
| 92 |
Session 3: Cancer IIWednesday 12th November 2008. Moderator: H. Peter Vollmers
|
|
|
2008
|
|
1-2 |
p. 5-6
|
artikel
|
| 93 |
Session 2: Cancer IMonday 29th October 2007. Moderators: Zdenka Jonak and Mark Glassy
|
|
|
2008
|
|
1-2 |
p. 3-4
|
artikel
|
| 94 |
Session 2: Cancer IWednesday 12th November 2008. Moderator: Mark Glassy
|
|
|
2008
|
|
1-2 |
p. 3-4
|
artikel
|
| 95 |
Session 12: Closing plenary lectureWednesday 31st October 2007. Moderator: Mark Glassy
|
|
|
2008
|
|
1-2 |
p. 43
|
artikel
|
| 96 |
Session 3: Emerging technologies
|
|
|
2002
|
|
1-2 |
p. 13-15
|
artikel
|
| 97 |
Session 5: HIVThursday 13th November 2008. Moderator: Mirek Gorny
|
|
|
2008
|
|
1-2 |
p. 11-13
|
artikel
|
| 98 |
Session 7: ImmunomodulationThursday 13th November 2008. Moderator: Mark Glassy
|
|
|
2008
|
|
1-2 |
p. 17-19
|
artikel
|
| 99 |
Session 6: Infectious disease
|
|
|
2006
|
|
1-2 |
p. 29-31
|
artikel
|
| 100 |
Session 8: Infectious diseases
|
|
|
2002
|
|
1-2 |
p. 25-28
|
artikel
|
| 101 |
Session 6: Infectious diseases
|
|
|
2004
|
|
1-2 |
p. 15-19
|
artikel
|
| 102 |
Session 5: Infectious diseases - I
|
|
|
2003
|
|
1-2 |
p. 11-12
|
artikel
|
| 103 |
Session 6: Infectious diseases - II
|
|
|
2003
|
|
1-2 |
p. 13-14
|
artikel
|
| 104 |
Session 9: Infectious diseases IIWednesday 31st October 2007. Moderator: Roberto Burioni
|
|
|
2008
|
|
1-2 |
p. 33-34
|
artikel
|
| 105 |
Session 7: Infectious diseases ITuesday 30th October 2007. Moderator: Alois Lang
|
|
|
2008
|
|
1-2 |
p. 27-29
|
artikel
|
| 106 |
Session 6: Infectious diseasesThursday 13th November 2008. Moderator: Robero Burioni
|
|
|
2008
|
|
1-2 |
p. 15-16
|
artikel
|
| 107 |
Session 4: Molecular biology (I)
|
|
|
2002
|
|
1-2 |
p. 17-18
|
artikel
|
| 108 |
Session 7: Molecular biology - I
|
|
|
2003
|
|
1-2 |
p. 15-19
|
artikel
|
| 109 |
Session 4: Molecular biology - I
|
|
|
2006
|
|
1-2 |
p. 15-17
|
artikel
|
| 110 |
Session 7: Molecular biology - I
|
|
|
2004
|
|
1-2 |
p. 21-25
|
artikel
|
| 111 |
Session 5: Molecular biology (II)
|
|
|
2002
|
|
1-2 |
p. 19-20
|
artikel
|
| 112 |
Session 8: Molecular biology - II
|
|
|
2003
|
|
1-2 |
p. 21-23
|
artikel
|
| 113 |
Session 5: Molecular biology - II
|
|
|
2006
|
|
1-2 |
p. 19-28
|
artikel
|
| 114 |
Session 8: Molecular biology - II
|
|
|
2004
|
|
1-2 |
p. 27-30
|
artikel
|
| 115 |
Session 7: Molecular biology (III)
|
|
|
2002
|
|
1-2 |
p. 21-23
|
artikel
|
| 116 |
Session 8: Molecular biology IITuesday 30th October 2007. Moderator: To be confirmed
|
|
|
2008
|
|
1-2 |
p. 31-32
|
artikel
|
| 117 |
Session 4: Molecular biology IMonday 29th October 2007. Moderators: Jim W. Larrick and Sachdev Sidhu
|
|
|
2008
|
|
1-2 |
p. 13-22
|
artikel
|
| 118 |
Session 10: New approachesFriday 14th November 2008. Moderator: Mark Glassy
|
|
|
2008
|
|
1-2 |
p. 29-31
|
artikel
|
| 119 |
Session 1: Opening plenary session
|
|
|
2004
|
|
1-2 |
p. 1
|
artikel
|
| 120 |
Session 1: Opening plenary session
|
|
|
2003
|
|
1-2 |
p. 1
|
artikel
|
| 121 |
Session 1: Opening plenary sessionMonday 29th October 2007. Moderator: Mark Glassy
|
|
|
2008
|
|
1-2 |
p. 1
|
artikel
|
| 122 |
Session 1: Opening plenary sessionWednesday 12th November 2008. Moderator: Mark Glassy
|
|
|
2008
|
|
1-2 |
p. 1
|
artikel
|
| 123 |
Session 9: Therapeutic antibodies: CancerFriday 14th November 2008. Moderator: Zdenka Jonak
|
|
|
2008
|
|
1-2 |
p. 25-27
|
artikel
|
| 124 |
Session 8: Therapeutic antibodies: InfectionThursday 13th November 2008. Moderator: Alois Lang
|
|
|
2008
|
|
1-2 |
p. 21-23
|
artikel
|
| 125 |
Surveillance of natural acquired antibodies to Haemophilus influenzae type b among children in Cairo-Egyptian
|
EL-Rashdy M. Redwan
|
|
2006
|
|
1-2 |
p. 23-26
|
artikel
|
| 126 |
Targeted therapy of solid tumors by monoclonal antibody specific to epidermal growth factor receptor
|
Baradaran, Behzad
|
|
2015
|
|
1-2 |
p. 13-20
|
artikel
|
| 127 |
Targeted therapy of solid tumors by monoclonal antibody specific to epidermal growth factor receptor
|
Baradaran, Behzad
|
|
2015
|
|
1-2 |
p. 13-20
|
artikel
|
| 128 |
The effect of Base Transceiver Station waves on some immunological and hematological factors in exposed persons
|
Taheri, Mohammad
|
|
2017
|
|
1-2 |
p. 31-37
|
artikel
|
| 129 |
The pharmacokinetics of ^{131}I-rituximab in a patient with CD20 positive Non-Hodgkin Lymphoma: Evaluation of the effect of radioiodination on the biological properties of rituximab
|
Tran, L.
|
|
2011
|
|
1-2 |
p. 37-40
|
artikel
|
| 130 |
Three decades of human monoclonal antibodies: Past, present and future developments
|
Steinitz, Michael
|
|
2009
|
|
1-2 |
p. 1-10
|
artikel
|
| 131 |
TRAIL gene expression analysis in multiple sclerosis patients
|
Taheri, Mohammad
|
|
2016
|
|
1-2 |
p. 33-38
|
artikel
|
| 132 |
Tumor angiogenesis and anti-angiogenic therapies
|
Shahneh, Fatemeh Zare
|
|
2013
|
|
1-2 |
p. 15-19
|
artikel
|
Tijdschrift beschrijving